---
title: "Salarius Pharmaceuticals becomes Decoy Therapeutics with Nasdaq ticker DCOY, emphasizing peptide conjugate therapeutics."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272569856.md"
description: "Salarius Pharmaceuticals has rebranded as Decoy Therapeutics, now trading under the Nasdaq ticker DCOY. The company is focusing on peptide conjugate therapeutics. Meanwhile, the global COVID-19 situation remains critical, with over 10 million confirmed cases and a death toll exceeding 500,000. Despite lockdowns, some regions face a resurgence in cases, prompting health officials to stress the importance of safety guidelines. Researchers are actively working on vaccine development, with several candidates in clinical trials as governments adapt their strategies to combat the pandemic."
datetime: "2026-01-14T14:20:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272569856.md)
  - [en](https://longbridge.com/en/news/272569856.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272569856.md)
---

# Salarius Pharmaceuticals becomes Decoy Therapeutics with Nasdaq ticker DCOY, emphasizing peptide conjugate therapeutics.

In the latest update, it has been reported that the number of confirmed COVID-19 cases has reached over 10 million worldwide, with the death toll surpassing 500,000. Despite efforts to control the spread through lockdowns and social distancing measures, some countries are experiencing a resurgence in cases, leading to concerns about a second wave of infections. Health officials are urging the public to continue following safety guidelines to prevent further outbreaks. In the meantime, researchers are working tirelessly to develop a vaccine, with several promising candidates currently in clinical trials. As the situation continues to evolve, governments and communities are adapting their strategies to mitigate the impact of the pandemic.

### Related Stocks

- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [SLRX.US](https://longbridge.com/en/quote/SLRX.US.md)

## Related News & Research

- [FACTBOX-Bundibugyo Ebola vaccines and treatments in development](https://longbridge.com/en/news/287257711.md)
- [4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy](https://longbridge.com/en/news/286655317.md)
- [US working with small biotech firm on experimental Ebola treatment, Bloomberg News reports](https://longbridge.com/en/news/287108072.md)
- [Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy | AVAI Stock News](https://longbridge.com/en/news/287067719.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)